Gurská Soňa Ph.D.

Phone: +420 585632069

Groups: IMTM, LEM, STAFF

I am working in the high throughput screening facility with focus on the testing of new chemical compounds, the implementation and validation of new biochemical and cell based assays into HTS. I am interested in identifying the active substances as potential drugs. I am experienced in liquid handling and robotic automation. Previously I was working in a field of mutagenesis and carcinogenesis at Cancer Reasearch Institute in Bratislava.

TANGALLAPALLI, S., R. GUNDLA, K. PAIDIKONDALA, S. GURSKÁ, N. RAMPEESA, S. ANUGU, P. DŽUBÁK, M. HAJDÚCH, V. DAS, N. KATARI

Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID: 41356712, PDF.

ORSÁG, Š., I. FRYDRYCH, B. LIŠKOVÁ, S. GURSKÁ, A. PRIBYLKA, J. HODOŇ, P. DŽUBÁK, M. HAJDÚCH, M. URBAN

Synthesis and biological evaluation of novel C-30 modified lupane triterpenoids selectively cytotoxic against cancer cells. European Journal of Medicinal Chemistry. 2025, 302 (Pt 1), 118268, ISSN: 0223-5234 , PMID: 41124881, PDF.

SROVNALOVÁ, A., R. KAPLANEK, Z. KEJIK, J. HAJDUCH, S. GURSKÁ, P. MARTASEK, M. HAJDÚCH, P. DŽUBÁK, M. JAKUBEK

Synthesis and evaluation of cyclobut-3-ene-1,2-dione-3-hydrazones with benzothiazole moiety as novel anticancer agents inducing nonapoptotic oncosis-like cell death. Biomedicine & pharmacotherapy. 2025, ISSN: 0753-3322, PMID: 40763487,

Gurská Soňa Ph.D.

About me

Journals